Facilitating Participation in Clinical Data Registries Act of 2015
Legislative Progress
Introduced
February 13, 2015
Latest Action
February 20, 2015
Primary Sponsor
Bill Pascrell, Jr.Democratic(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
7d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Facilitating Participation in Clinical Data Registries Act of 2015 This bill requires the Office for Human Research Protections of the Department of Health and Human Services to issue guidance within one year on the application of the Common Rule, which provides protections for human research subjects, to clinical data registries.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2016 · third_quarter · Medicare/Medicaid
Advocate regarding proposed regulations under Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Support legislation to have telemedicine services reimbursable by Medicare (S. 2484/ H.R. 4442, the Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act). Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program (, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, HR 5001/S.2822 Flexibility in Electronic Health Record Reporting Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S.2511, Improving Health Information Technology Act). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act. Advocate for improving disease management and care coordination for patients with chronic diseases Support preservation of the In Offices Ancillary Services Exemption under Stark Law regarding physician self-referral. Advocate against H.R. 5008, Promoting Integrity in Medicare Act of 2016 Support legislation to provide more flexibility in compliance with the Sunshine Act (S.2978). Advocate against data blocking by Electronic Health Records vendors. Support legislation to have telemedicine services reimbursable by Medicare (S. 2484/H.R. 4442, the Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act). Support S. 2978, Protecting Continuing Physician Education & Patient Care Act. Advocate for increased graduate medical education funding. Lobby members of House to write to CMS in opposition of a policy in the 2017 Medicare Physician Fee Schedule Proposed Rule that would require all physicians to collect and report data on all services included in 10- and 90-day global surgery codes.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $470,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
Advocate regarding proposed regulations under Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program (, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, HR 5001/S.2822 Flexibility in Electronic Health Record Reporting Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S.2511, Improving Health Information Technology Act). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act. Advocate for improving disease management and care coordination for patients with chronic diseases Support preservation of the In Offices Ancillary Services Exemption under Stark Law regarding physician self-referral. Advocate against H.R. 5008, Promoting Integrity in Medicare Act of 2016 Support legislation to provide more flexibility in compliance with the Sunshine Act (S.2978). Advocate against data blocking by Electronic Health Records vendors. Support legislation to have telemedicine services reimbursable by Medicare (S. 2484/ H.R. 4442, the Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act). Support S. 2978, Protecting Continuing Physician Education & Patient Care Act. Advocate for increased graduate medical education funding.
Client expense: $400,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Medicare/Medicaid
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program (H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act) Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S.2511, Improving Health Information Technology Act). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act. Advocate for improving disease management and care coordination for patients with chronic diseases Support preservation of the In Offices Ancillary Services Exemption under Stark Law regarding physician self-referral; respond to request for comment regarding possible changes to Stark Law.
Client expense: $444,057 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medicare/Medicaid
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.
Client expense: $280,332 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Medicare/Medicaid
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act
Client expense: $442,136 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Medicare/Medicaid
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.
2015 · first_quarter · Medicare/Medicaid
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Advocate regarding CMS global payment proposal, data registry issues, electronic health record and Medicare policies in 21st Century cures initiative.
2015 · first_quarter · Medicare/Medicaid
S. 141, Protecting Seniors' Access to Medicare Act of 2015: To repeal the Independent Payment Advisory Board. S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015: To repeal the Medicare sustainable growth rate. H.R. 2, Medicare Access and CHIP Reauthorization Act: To repeal the Medicare sustainable growth rate and reauthorize the Children's Health Insurance Program. H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015: To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs. H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015: To require the issuance of guidance on the application of the Federal policy for the protection of human subjects with respect to clinical data registries. H.R. 1021, Protecting the Integrity of Medicare Act of 2015: To improve the integrity of the Medicare program (includes Common Rule provision). H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015: To repeal Independent Payment Advisory Board. H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015: To repeal the Medicare sustainable growth rate.
Client expense: $50,000 · Firm income: Not reported
2015 · first_quarter · Medicare/Medicaid
S. 141, Protecting Seniors' Access to Medicare Act of 2015: To repeal the Independent Payment Advisory Board. S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015: To repeal the Medicare sustainable growth rate. H.R. 2, Medicare Access and CHIP Reauthorization Act: To repeal the Medicare sustainable growth rate and reauthorize the Children's Health Insurance Program. H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015: To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs. H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015: To require the issuance of guidance on the application of the Federal policy for the protection of human subjects with respect to clinical data registries. H.R. 1021, Protecting the Integrity of Medicare Act of 2015: To improve the integrity of the Medicare program (includes Common Rule provision). H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015: To repeal Independent Payment Advisory Board. H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015: To repeal the Medicare sustainable growth rate.
Client expense: $50,000 · Firm income: Not reported
Client expense: $377,934 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $409,031 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE